Advertisement.

OPT Projected Dividend Yield

ADR (Sponsored) (New)/Opthea Ltd ( NASDAQ : OPT )

Opthea is a biopharmaceutical company. Co. develops and commercializes therapies mainly for eye disease. Co.'s primary asset, OPT-302, is a soluble form of Vascular Endothelial Growth Factors (VEGF) Receptor-3 in clinical development as a therapy for wet (neovascular) age-related macular degeneration (Wet AMD) and diabetic macular edema (DME). Wet AMD and DME are the main causes of blindness in the elderly and diabetic populations respectively. Co.'s development activities are based on an intellectual property portfolio covering primary targets (VEGF-C, VEGF-D and VEGF Receptor-3) for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

20 YEAR PERFORMANCE RESULTS

OPT Dividend History Detail
OPT Dividend News
OPT Competitors News

# of Shares: 0

Closing Price: 3.25

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000